529 related articles for article (PubMed ID: 21600985)
1. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
Sciolino NR; Zhou W; Hohmann AG
Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
[TBL] [Abstract][Full Text] [Related]
2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
3. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
Guindon J; Guijarro A; Piomelli D; Hohmann AG
Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
[TBL] [Abstract][Full Text] [Related]
4. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
[TBL] [Abstract][Full Text] [Related]
7. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
[TBL] [Abstract][Full Text] [Related]
8. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB
Ivy D; Palese F; Vozella V; Fotio Y; Yalcin A; Ramirez G; Mears D; Wynn G; Piomelli D
Neuropsychopharmacology; 2020 Jul; 45(8):1330-1338. PubMed ID: 32375160
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.
Chen X; Zhang J; Chen C
Neuroscience; 2011 Mar; 178():159-68. PubMed ID: 21256197
[TBL] [Abstract][Full Text] [Related]
11. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
[TBL] [Abstract][Full Text] [Related]
13. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP
Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700
[TBL] [Abstract][Full Text] [Related]
14. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
Wang J; Zhang X; Yang C; Zhao S
Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory and inhibitory roles of brain 2-arachidonoylglycerol in bombesin-induced central activation of adrenomedullary outflow in rats.
Shimizu T; Tanaka K; Yokotani K
J Pharmacol Sci; 2013; 121(2):157-71. PubMed ID: 23386378
[TBL] [Abstract][Full Text] [Related]
16. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.
Long JZ; Nomura DK; Cravatt BF
Chem Biol; 2009 Jul; 16(7):744-53. PubMed ID: 19635411
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
18. Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.
Zhang Z; Wang W; Zhong P; Liu SJ; Long JZ; Zhao L; Gao HQ; Cravatt BF; Liu QS
Hippocampus; 2015 Jan; 25(1):16-26. PubMed ID: 25131612
[TBL] [Abstract][Full Text] [Related]
19. Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol.
Petrenko AB; Yamazaki M; Sakimura K; Kano M; Baba H
Behav Brain Res; 2014 Sep; 271():51-8. PubMed ID: 24906199
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
Lau BK; Drew GM; Mitchell VA; Vaughan CW
Br J Pharmacol; 2014 Dec; 171(23):5225-36. PubMed ID: 25041240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
